tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2023 Jan 11;10(1)
fad009.
doi: 10.1093/ofid/ofad009. eCollection 2023 Jan.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Short- and Mid-term Cardiac Outcomes in Multisystem Inflammatory Syndrome in Children
Swetha Pinninti[SUP] 1 [/SUP], Camden Hebson[SUP] 2 [/SUP], Jacqueline Collins[SUP] 2 [/SUP], Connie Trieu[SUP] 3 [/SUP], Sushma Boppana[SUP] 4 [/SUP], Markus Buchfellner[SUP] 1 [/SUP], Cathy Seripin[SUP] 5 [/SUP], April Yarbrough[SUP] 5 [/SUP], Claudette Poole[SUP] 1 [/SUP], Shannon Ross[SUP] 1 [/SUP], Scott James[SUP] 1 [/SUP], Cecelia Hutto[SUP] 1 [/SUP], Suresh Boppana[SUP] 1 [/SUP]
Affiliations
Abstract
Cardiac outcomes of 131 children with multisystem inflammatory syndrome (MIS-C) were examined. The majority of the cohort was male (66.4%) and half were Black (49.6%). Cardiac involvement was evident in 25% of the cohort at diagnosis. Favorable short- and mid-term outcomes were documented on follow-up, irrespective of the severe acute respiratory syndrome coronavirus 2 variants causing the infection.
Keywords: MIS-C; SARS-CoV-2; cardiac.
. 2023 Jan 11;10(1)
fad009.doi: 10.1093/ofid/ofad009. eCollection 2023 Jan.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Short- and Mid-term Cardiac Outcomes in Multisystem Inflammatory Syndrome in Children
Swetha Pinninti[SUP] 1 [/SUP], Camden Hebson[SUP] 2 [/SUP], Jacqueline Collins[SUP] 2 [/SUP], Connie Trieu[SUP] 3 [/SUP], Sushma Boppana[SUP] 4 [/SUP], Markus Buchfellner[SUP] 1 [/SUP], Cathy Seripin[SUP] 5 [/SUP], April Yarbrough[SUP] 5 [/SUP], Claudette Poole[SUP] 1 [/SUP], Shannon Ross[SUP] 1 [/SUP], Scott James[SUP] 1 [/SUP], Cecelia Hutto[SUP] 1 [/SUP], Suresh Boppana[SUP] 1 [/SUP]
Affiliations
- PMID: 36686629
- PMCID: PMC9850272
- DOI: 10.1093/ofid/ofad009
Abstract
Cardiac outcomes of 131 children with multisystem inflammatory syndrome (MIS-C) were examined. The majority of the cohort was male (66.4%) and half were Black (49.6%). Cardiac involvement was evident in 25% of the cohort at diagnosis. Favorable short- and mid-term outcomes were documented on follow-up, irrespective of the severe acute respiratory syndrome coronavirus 2 variants causing the infection.
Keywords: MIS-C; SARS-CoV-2; cardiac.